UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): March 19, 2015

                                 AMERICANN, INC.
                      -------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                    000-54231                27-4336843
  ------------------------       -----------------        -----------------
(State or other jurisdiction    (Commission File No.)      (IRS Employer
  of incorporation)                                       Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                 ----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

                                       N/A
                -------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01.  Entry Into a Material Definitive Agreement

     On March 19, 2015  AmeriCann  borrowed  $650,000 from an unrelated  private
investor.  The loan is secured by certain assets of the company, has a six-month
term and bears interest at 14% per annum with no equity conversion rights.

     The proceeds from the loan will be used for general corporate  purposes and
for additional funding of the company's Illinois Medical Cannabis Center (IMMC),
a new medical cannabis  production and processing facility which will be located
on a 17-acre  parcel  in  southern  Illinois.  The IMCC is home to one of the 18
licensed   cultivation  and  processing   operations  allowed  under  the  newly
implemented  Illinois Medical  Cannabis Pilot Program.  Construction of the IMMC
began in February of 2015.

Item 2.03.  Creation of a Direct  Financial  Obligation or an Obligation Under
            an Off-Branch Sheet Arrangement of a Registrant

     See Item 1.01 of this report.

Item 8.01   Other Events

     The Company's  board of directors has agreed to the creation of an Advisory
Board that will consist of individuals whom the directors believe can assist the
Company in the  implementation  of its  business.  The board also  agreed to the
establishment  of a stock  option  plan  that will be used as an  incentive  for
present and future employees, partners, consultants and Advisory Board members.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: March 25, 2015
                                      AMERICANN, INC.


                                      By: /s/ Timothy Keogh
                                          -------------------------------------
                                          Timothy Keogh, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101march-15.txt", "description": "8-K RE LOAN & STK OPTION PLAN", "secsgml_size_bytes": 3998}]
{"company-data": {"conformed-name": "Americann, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "15728812"}, "business-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(303) 839-0061"}, "mail-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): March 19, 2015

                                 AMERICANN, INC.
                      -------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                    000-54231                27-4336843
  ------------------------       -----------------        -----------------
(State or other jurisdiction    (Commission File No.)      (IRS Employer
  of incorporation)                                       Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                 ----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

                                       N/A
                -------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

     On March 19, 2015  AmeriCann  borrowed  $650,000 from an unrelated  private
investor.  The loan is secured by certain assets of the company, has a six-month
term and bears interest at 14% per annum with no equity conversion rights.

     The proceeds from the loan will be used for general corporate  purposes and
for additional funding of the company's Illinois Medical Cannabis Center (IMMC),
a new medical cannabis  production and processing facility which will be located
on a 17-acre  parcel  in  southern  Illinois.  The IMCC is home to one of the 18
licensed   cultivation  and  processing   operations  allowed  under  the  newly
implemented  Illinois Medical  Cannabis Pilot Program.  Construction of the IMMC
began in February of 2015.

Item 2.03.  Creation of a Direct  Financial  Obligation or an Obligation Under
            an Off-Branch Sheet Arrangement of a Registrant

     See Item 1.01 of this report.

Item 8.01   Other Events

     The Company's  board of directors has agreed to the creation of an Advisory
Board that will consist of individuals whom the directors believe can assist the
Company in the  implementation  of its  business.  The board also  agreed to the
establishment  of a stock  option  plan  that will be used as an  incentive  for
present and future employees, partners, consultants and Advisory Board members.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: March 25, 2015
                                      AMERICANN, INC.

                                      By: /s/ Timothy Keogh
                                          -------------------------------------
                                          Timothy Keogh, Chief Executive Officer